News & Blog

Fibronostics Raises $8 Million in Series A Financing

Fibronostics, a global company providing non-invasive, algorithmic diagnostics for NASH patients, announced today that it has secured $8 million in series A funding. The financing round was led by AT Capital, a leading private investment firm in Asia and Elev8.vc, an early-stage deep-tech VC fund. … Read More 

Fibronostics Appoints Dr. Stephen A. Harrison to its Board of Advisors

Fibronostics, a global diagnostics company, providing non-invasive, algorithmic diagnostics to detect and manage metabolic diseases, announced today Stephen A. Harrison, MD has joined its board of advisors. … Read More 

The Critical Need for Virtual COVID-19 Clinical Trials and Patient Training

COVID-19 drug development has brought a unique set of clinical challenges, virtual patient training and decentralized trials can be part of the solution. … Read More 

Case Studies

Adapting Presentation Material to Best Suit the Needs of Millennial Dental Students

A top US-based, multi-national oral care brand seeking to revamp its educational materials to better accommodate the evolving needs of a dental student population now primarily dominated by millennials. … Read More 

Thought Leadership and Education in a Growing Industry

A leading provider of high-quality, direct-to-consumer (DTC) dietary supplements sought out opportunities to build thought leadership in a rapidly growing market category. As competition increased via the introduction of mediocre players and formulas, a differentiation strategy that focused attention on the importance of quality was critical. … Read More 

Addressing the Needs of the Lupus Community

The global supply leader of Antarctic krill oil set a mission to improve the lives of systemic lupus erythematosus (SLE) patients. SPRIM helped the client understand the lupus community through qualitative and quantitative research. … Read More